1006724-55-5
1006724-55-5
Chemical Structure
Alfuzosin-d3
Synonym(s): SL 77499-d3
- CAS No.: 1006724-55-5
- Formula:C19H24D3N5O4
- Molecular Weight:392.47
IUPAC Name: N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl-d3)amino)propyl)tetrahydrofuran-2-carboxamide
InChIKey: WNMJYKCGWZFFKR-FIBGUPNXSA-N
SMILES: NC1=NC(N(C([2H])([2H])[2H])CCCNC(C2CCCO2)=O)=NC3=C1C=C(OC)C(OC)=C3
Biological Activity: Alfuzosin-d3 is deuterium labeled Alfuzosin.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Alfuzosin-d3 | 99.90% | Alfuzosin-d3 is deuterium labeled Alfuzosin. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Alfuzosin (Standard) | ≥98% | Alfuzosin (Standard) is the analytical standard of Alfuzosin. This product is intended for research and analytical applications. Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Alfuzosin-d7 | Alfuzosin-d7 is the deuterium labeled Alfuzosin. Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Alfuzosin-13C,d3 | Alfuzosin-13C,d3 is the 13C- and deuterium labeled Alfuzosin. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Alfuzosin-d6 | Alfuzosin-d6 (SL 77499-d6) is deuterium labeled Alfuzosin. Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Alfuzosin | 99.86% | Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
